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Objective: To determine the prevalence of hand and wrist 
symptoms and impairments, and the resulting activity limi-
tations in relation to disease duration in patients with rheu-
matoid arthritis.
Design and patients: A cross-sectional study included 200 
consecutive patients with rheumatoid arthritis in 4 catego-
ries of disease duration: 2–4, 4–6, 6–8 and ≥ 8 years. Patients 
were asked about the presence of various hand and wrist 
symptoms, and underwent a standardized physical examina-
tion. To evaluate activity limitations, patients completed the 
Disabilities of the Arm Shoulder and Hand questionnaire 
and scored their limitations on a Numerical Rating Scale 
(0 = no to 10 = maximum limitation).
Results: Of all patients, 94% suffered from at least one 
symptom, and 67% had at least one impairment, mostly 
from the earliest stages onwards. The median standardized 
Disabilities of the Arm Shoulder and Hand score (interquar-
tile range) was 26.7 (10.8–42.5). The mean Numerical Rating 
Scale score for activity limitations was 2.99 (standard devia-
tion 2.50) in the dominant hand and 2.59 (standard deviation 
2.49) in the non-dominant hand.
Conclusion: A high prevalence of hand and wrist symptoms 
and impairments is often already present after 2 years of 
disease duration. We recommend that physicians specifically 
screen for these symptoms and impairments, starting 2 years 
after the diagnosis of rheumatoid arthritis.
Key words: rheumatoid arthritis; hand; symptoms and impair-
ments.
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INTRoDuCTIoN
In the early stages of rheumatoid arthritis (RA) involvement 
of the hand and wrist is commonly described, causing pain, 
limited range of motion and/or loss of muscle strength. Previ-
ous studies have reported 28% hand involvement and 8% wrist 
involvement at the onset of the disease (1–3). In a small cohort 
of patients with early onset arthritis metacarpophalangeal 
(MCP) joint or wrist deformities were observed by magnetic 
resonance imaging in approximately 90% of the patients (4). 
Data prior to 2000 show that, during the course of the disease, 
90% of RA patients eventually develop hand deformities (1, 5). 
However, this percentage is likely to decrease with the advent 
of more effective pharmacological treatment regimens that can 
be started early in the course of the disease (6).
Synovitis and tenosynovitis are the first symptoms (4), which 
may eventually result in the destruction of joints, laxity of 
ligaments and imbalance of muscle function. As this process 
progresses over time, impairments reinforce each other in 
such a way that serious deformities can eventually develop, 
and these can lead to limitations in activities of daily living. 
However, we lack information concerning the precise course 
of such deteriorations. It is important to gain insight into the 
sequence of these early symptoms in the hand and wrist and 
how they develop over time, in order to provide adequate 
non-pharmacological treatment, i.e. exercises, massage and 
information on hand-use, in combination with splinting, injec-
tion therapy or surgical interventions.
In addition to the lack of knowledge about hand and wrist 
impairments, little is known about the resulting activity limi-
tations. With more knowledge it might be possible to design 
a screening protocol to aid the development of a therapeutic 
or preventive non-pharmacological intervention, which could 
then be tested in a randomized trial. 
As a first step we performed a cross-sectional study within an 
ongoing longitudinal cohort study, to determine the prevalence 
of hand and wrist symptoms, impairments, and activity limita-
tions in relation to disease duration in patients with RA after 
the establishment of adequate pharmacological treatment.
PATIeNTS AND MeTHoDS
Patients
In this cross-sectional study, the study population consisted of con-
secutive patients from an ongoing care and research cohort: the early 
Arthritis Clinic (eAC) of the Jan van Breemen Institute in Amsterdam, 
a large clinic for rheumatology and rehabilitation medicine in the 
Netherlands. The eAC provides an extensive source of data in which 
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all patients ≥ 18 years of age, with arthritis in ≥ 2 joints and ≤ 3 years 
of symptoms have been monitored since 1995 with regular follow-up 
visits. The inclusion criteria for the present study were, eAC patients, 
fulfilling the American College of Rheumatology criteria for RA (7) at 
baseline and/or 1 year after inclusion in the cohort, and at least 2 years 
of follow-up in this cohort. Patients with spondylarthropathy, reactive 
arthritis, crystal-induced arthropathy, systemic lupus erythematosus, 
Sjögren’s syndrome or osteoarthritis were excluded. 
Patients were included in 4 categories of disease duration: 2–4 
years, 4–6 years, 6–8 years and ≥ 8 years, and were invited to attend 
our Department of Rehabilitation Medicine. Patients with a disease 
duration of less than 2 years were not included, because the first 2 years 
are considered to be necessary to establish adequate pharmacological 
treatment. In patients with a disease duration of more than 2 years, we 
chose 4 categories with small intervals of disease duration (i.e. 2 years), 
because we wanted to know at what moment in time hand problems 
arise. Recruitment continued until 50 patients were included in each 
subgroup of disease duration, with a total of 200 patients. The reasons 
patients gave for non-participation were registered. All participants 
gave written informed consent, and the study protocol was approved 
by the local medical ethics committee. 
Disease information
Data concerning disease duration, the nearest scores at the time of as-
sessment of the disease activity (Disease Activity Score in 28 joints: 
DAS28) (8) and radiographically determined joint damage (Sharp van 
der Heijde score: SHS) (9) were collected from the eAC database. Also 
collected from this database was the nearest score at the time of assess-
ment for the Dutch version of the Health Assessment Questionnaire 
(HAQ), together with the category score for HAQ-grip (10, 11). 
Symptoms
The patients were asked about the presence or absence of various 
hand and wrist symptoms that bothered them: pain, stiffness, muscle 
weakness, paraesthesia, limited fist, limited pinch grip, joint deviation, 
aesthetics, or other complaints. Furthermore, pain was assessed ac-
cording to a Numerical Rating Scale (NRS) ranging from 0–10 (0 = no 
pain at all, 10 = unbearable pain).
Impairments 
A standardized physical examination of the hand and wrist was per-
formed to test for joint mobility, any dislocation or deviation of joints, 
tendon-gliding, signs of (teno)synovitis, and nerve function (12). Joint 
mobility was considered to be impaired if the passive measurement 
was ≥ 15 degrees less than the norm values (13–15). Involvement 
of the first carpometacarpal (CMC-1) joint was scored positive if 
passive motion of this joint was painful, and when the CMC-1 joint 
was prominent during inspection of the hand contour. Z-deformity of 
the thumb was scored positive if, on inspection, there was a flexed 
MCP-1 joint and a hyperextended interphalangeal joint that could 
not be actively corrected. Flexor tendon-gliding was graded with the 
Amsterdam Severity Scale in Stenosing Tenosynovitis (range 0–3) 
because of its high inter-observer reliability (16). Tenosynovitis ≥ 
grade 2 was considered to indicate impairment, in which a perceptible 
click or a reduced tempo of active finger flexion was observed, in 
combination with a full active range of motion (aRoM) (determined 
by the maximum pRoM). Grade 3 indicates a restriction in aRoM 
due to tendon blockade under the pulleys or within the tendon sheath. 
A swollen extensor tendon sheath with palpation was interpreted as 
tendinitis in this tendon. Nerve function, focused on signs of carpal 
tunnel syndrome (CTS), was assessed with the Hoffman-Tinel test and 
the Phalen manoeuvre (17). 
A total of 182 patients underwent a physical examination, performed 
by one of two rehabilitation physicians (NCAH and AFH). The physical 
examination of 18 patients was independently performed by both 
assessors on the same day, to assess for inter-observer reliability 
(inter-rater agreement was 88%, ranging from 78% to 94% for the 
different impairments).
Activity limitations
The patients completed the validated Dutch version of the Disabilities 
of the Arm, Shoulder and Hand (DASH) questionnaire to measure self-
rated upper-extremity disability and symptoms (18–20). The DASH 
is a 30-item questionnaire assessing ability to perform activities of 
daily living (ADL), limitations in social activities, pain, sleep, and 
self-consciousness. each item is scored on a scale ranging from 1 
(“no problem at all”) to 5 (“impossible to perform this activity”), and 
the summed scores are transformed to a standardized score (0–100), 
with higher scores indicating more limitations. Furthermore, patient-
reported activity limitations were assessed according to an NRS, 
ranging from 0–10 (0 = no activity limitations, 10 = severe activity 
limitations), when asked “how do you describe your ability to use 
your hands in daily activities”. 
Statistical analysis
The mean age and median disease duration were calculated at the time 
of assessment and percentages were calculated to determine the preva-
lence of presence of symptoms and impairments. For the assessment of 
activity limitations, the mean standardized DASH score (21) and the 
mean NRS score for use of the hands were calculated. A distinction 
was made between the dominant hand and the non-dominant hand. 
Differences between the 4 disease duration groups were investigated 
with a χ2 test for trend (dichotomous variables) or an one-way analysis 
of variance (other variables). In a secondary analysis, differences 
between patients with a disease duration of < 8 years and ≥ 8 years were 
investigated with an χ2 test (dichotomous variables) or a 1-way analysis 
of variance (other variables). p-values of ≤ 0.05 were considered to be 
statistically significant, and all analyses were performed with SPSS 
version 15.0 (SPSS, Chicago, IL, uSA).
ReSuLTS
Patients
A total of 366 patients were invited to participate, 166 of whom 
were unwilling to participate after receiving an invitation for 
the assessment. Their reasons for non-participation were: 
logistical problems (19%), no specific reason (51%), no hand 
symptoms (2%), or no reason given (28%). The characteristics 
of the participants and the non-participants are presented in 
Table I. The two groups were comparable with regard to gender, 
marital status, mean disease duration, IgM-rheumatoid factor 
positivity, anti-cyclic citrullinated peptide (aCCP) positivity, 
SHS, DAS28, HAQ and HAQ-grip. The participants were 
statistically significantly older, and tended to have a slightly 
higher DAS28 score than the non-participants.
Symptoms
The full results are presented in Table II. A total of 94% of the 
patients suffered from at least one hand or wrist symptom after 
2–4 years of disease duration. The symptoms that patients de-
scribed most frequently were pain, stiffness of the hand, muscle 
weakness, paraesthesia, and complaints concerning a limited 
fist. In general, no associations were found between symptoms 
and disease duration, except for stiffness of the hand, which 
patients experienced less with longer disease duration. Mean 
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and standard deviation (SD) NRS pain was 2.54 (SD 2.29) in 
the dominant hand and 2.11 (SD 2.19) in the non-dominant 
hand. Pain was not related to disease duration.
Impairments 
The results are presented in Table III. After 2–4 years of disease 
duration 70% of the patients were found, during the physical 
examination, to have at least one hand or wrist impairment in 
the dominant hand. This was found in the non-dominant hand 
in 66% of the patients. The most frequently found impairments 
were a limited passive range of motion (pRoM) of the wrist 
and finger joints, stenosing tenosynovitis, and involvement of 
the CMC-1 joint. In 6% of the patients there were signs of CTS 
in the dominant hand and in 8% in the non-dominant hand. 
Table III shows how these impairments were associated with 
disease duration. When comparing the sub-groups of disease 
duration, with the χ2 test for trend, there was a significantly 
higher prevalence of the following: limited pROM of finger 
joints in the dominant hand, Z-deformity of the non-dominant 
thumb, and tendinitis of the extensor tendons of the dominant 
hand in the sub-groups with a longer disease duration. There 
was also a significantly higher prevalence of limited pROM 
of finger joints in the non-dominant hand in the sub-group of 
patients with 8 or more years of disease duration, compared 
with the combined prevalence in the first 3 subgroups of 
disease duration.
Activity limitations
The median and interquartile range (IQR) standardized DASH 
score for all the included patients was 26.7 (IQR10.8–42.5). 
This is significantly higher than the normative DASH score 
for the general population, which is 10.1 (SD 14.7) (22). The 
DASH score was classified as abnormal if it was above the 
normative mean DASH score plus twice the SD (> 39.5). A 
total 30% of the patients had an abnormal DASH score. The 
mean (SD) NRS use of hands for all the included patients was 
2.99 (SD 2.50) in the dominant hand and 2.59 (SD 2.49) in the 
non-dominant hand. No association was found between these 
scores and the duration of the disease (Table IV).
Table I. Patient characteristics
Characteristics
Participants 
n = 200
Non-participants
n = 166
Age, years, mean (SD) 59.7 (10.7) 55.8 (13.8)
Female, % 75 68
Marital status 
Married/living together,%
Single/divorced, %
Widow(er), %
unknown
67
23
5
5
71
21
7
1
Disease duration, years,  
mean (SD)
5.9 (2.7) 5.4 (3.2)
Rheumatoid factor positive, % 48 48
aCCP positive, % 58 60
Sharp van der Heijde score, 
median (IQR)
6 (0–25) 4 (0–11)
DAS28, mean (SD) 3.12 (1.50) 2.82 (1.24)
HAQ, median (IQR) 0.75 (0.13–1.25) 0.75 (0.13–0.88)
HAQ-grip: presence of difficulty 
with grip, %
44 45
Differences between participants and non-participants were tested with a 
t-test (variables normally distributed), a Mann-Whitney U test (variables 
not normal distributed) or a χ2 test (categorical).
SD: standard deviation; aCCP: anti-cyclic citrullinated peptide; IQR: 
inter-quartile range; DAS28: Disease Activity Score of 28 joints; HAQ: 
Health Assessment Questionnaire. 
Table II. Prevalence of subjectively reported symptoms related to disease duration
2–4 years
n = 50
4–6 years
n = 52
6–8 years
n = 49
≥ 8 years
n = 49
p-value of test  
of difference 
between 4 disease 
duration groups† 
p-value of test 
of difference 
between groups 
< 8 and ≥ 8 years‡
Age, years, mean (SD) 58.3 (11.0) 57.9 (11.3) 62.4 (9.9) 60.4 (10.3) 0.14 0.61
Any symptom, % 94 100 92 92 0.86 0.59
Pain, % 93 92 87 87 0.20 0.42
Stiffness, % 82 75 76 60 0.03* 0.02*
Muscle weakness, % 73 56 69 80 0.26 0.07
Paraesthesia, % 42 25 38 24 0.21 0.21
Limited fist, % 24 25 24 33 0.37 0.25
Limited pinch grip, %
Joint deviation, %
Aesthetics, %
other, %
NRS pain, mean (SD)
 Dominant hand 
 Non-dominant hand
0
4
11
2
2.6 (2.3)
2.1 (2.2)
0
15
12
6
2.4 (2.3)
1.9 (1.9)
4
13
11
11
2.4 (2.6)
1.9 (2.2)
4
13
11
4
2.7 (2.8)
2.4 (2.5)
0.06
0.27
0.98
0.45
0.89
0.61
0.22
0.71
0.98
0.64
0.50
0.21
*p < 0.05.
†Differences in prevalence between 4 disease duration groups were investigated with an χ2 test for trend (dichotomous variables) or a one-way analysis 
of variance (NRS pain). 
‡In a secondary analysis, differences between patients with a disease duration of < 8 years and ≥ 8 years were investigated with a χ2 test (dichotomous 
variables) or a one-way analysis of variance (NRS pain). 
SD: standard deviation; NRS: Numerical Rating Scale. 
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DISCuSSIoN
Symptoms
Almost all the patients had at least one hand and wrist symptom. 
The prevalence of pain was high, although the pain was not very 
intense and had no association with disease duration. There was 
a high prevalence of reported stiffness of the hand, but with 
a significantly lower prevalence in sub-groups with a longer 
disease duration. Many patients reported muscle weakness, but 
this had no association with disease duration. The prevalence 
of symptoms was higher than expected, based on our clinical 
experience, also in the group with the shortest disease duration. 
This discrepancy might be explained by the fact that patients 
reported that normally they do not complain about their hand and 
wrist problems because they adapt to the situation, and because 
they do not expect any effective treatment to be available.
Impairments
A high prevalence of hand and wrist impairments was found. 
The prevalence of limited pROM of any finger joint in the 
Table III. Prevalence of objectively assessed impairments, related to disease duration 
Impairment
2–4 years
n = 50
4–6 years
n = 52
6–8 years
n = 49
≥ 8 years
n = 49
p-value of test of 
difference between 
4 disease duration 
groups† 
p-value of test of 
difference between 
groups < 8 and ≥ 8 
years‡
≥ 1 impairment
dominant hand, %
non-dominant hand, %
70
66
65
60
67
61
76
80
0.53
0.16
0.29
0.03*
Limited pRoM wrist
dominant hand, %
non-dominant hand, %
28
20
15
15
20
18
35
31
0.36
0.18
0.06
0.06
Limited pROM finger joints
dominant hand, %
non-dominant hand, %
28
26
21
29
29
27
49
43
0.02*
0.10
0.002*
0.04*
Stenosing tenosynovitis ≥ gr 2
dominant hand, %
non-dominant hand, %
24
26
19
17
22
18
20
20
0.78 
0.54
0.83
0.99
Involvement CMC-1 joint
dominant hand, %
non-dominant hand, %
18
16
17
17
27
22
31
31
0.08
0.06
0.15
0.07
Z-deformity thumb
dominant hand, %
non-dominant hand, %
2
0
15
10
12
10
12
16
0.15
0.002*
0.68
0.006*
Tendinitis of ext. tendons
dominant hand, %
non-dominant hand, %
2
2
2
0
2
4
12
4
0.02*
0.30
0.003*
0.41
Signs of CTS
dominant hand, %
non-dominant hand, %
6
8
10
6
4
6
2
6
0.23
0.74
0.22
0.90
*p < 0.05.
†Differences in prevalence between 4 disease duration groups were investigated with a χ2 test for trend. 
‡In a secondary analysis, differences between patients with a disease duration of < 8 years and ≥ 8 years were investigated with an χ2 test. 
pROM: passive range of motion; gr: grade; CMC-1: first carpometacarpophalangeal joint; ext: extensor; CTS: carpal tunnel syndrome. 
Table IV. Prevalence of activity limitations, related to disease duration
Disabilities
2–4 years
n = 50
4–6 years
n = 52
6–8 years
n = 49
≥ 8 years
n = 49
p-value of test of 
difference between 
4 disease duration 
groups†
p-value of test of 
difference between 
groups < 8 and ≥ 8 
years‡
DASH, median (IQR) 21.7 (10.4–37.7) 26.7 (12.5–41.3) 25.0 (7.5–45.4) 26.7 (9.1–48.3) 0.94 0.65
NRS, mean (SD)
dominant hand 3.1 (2.4) 2.8 (2.2) 2.8 (2.5) 3.1 (2.9) 0.83 0.57
non-dominant hand 2.3 (2.2) 2.7 (2.7) 2.5 (2.3) 2.9 (2.7) 0.66 0.37
*p < 0.05.
Prevalences were compared between all different disease duration groups.
†Analysis of variance with one-sided testing was applied to evaluate significance. 
‡In a secondary analysis, differences between patients with a disease duration of < 8 years and ≥ 8 years were investigated with a one-way analysis 
of variance. 
DASH: Disabilities of the Arm Shoulder and Hand questionnaire; IQR: inter-quartile range; SD: standard deviation; NRS: Numerical Rating Scale 
for patient- reported hand activity limitations. 
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dominant and non-dominant hand, and of Z-deformity of the 
non-dominant thumb was significantly higher in the sub-groups 
with a longer disease duration. In our opinion, it is important 
to diagnose a Z-deformity in an early stage in order to try to 
prevent or retard the development of irreversible joint contrac-
tures (which may lead to impaired grip function via splinting), 
and to provide information on use of the hands.
A high prevalence of stenosing tenosynovitis was found 
in all categories of disease duration. Awareness of this can 
be valuable in clinical practice because, in our experience, 
untreated stenosing tenosynovitis may eventually lead to MCP 
subluxation, caused by muscular imbalance, with dominat-
ing and shortening of intrinsic hand muscles. Treatment, via 
exercises, massage and information on use of the hands, in 
combination with splinting and once-only injection therapy, 
is most successful when initiated in grade 1 and in the early 
phase of grade 2 tenosynovitis; surgical intervention is needed 
for longer lasting grade 2, and also grade 3 tenosynovitis.
We found a low prevalence of tendinitis of the extensor ten-
dons, but in the dominant hand the prevalence was significantly 
higher in the sub-groups with a longer disease duration. Since 
longstanding (> 6 months) tendinitis increases the risk of exten-
sor tendon rupture (23, 24), timely recognition is important so 
that splinting treatment can be initiated. 
Activity limitations
The median standardized DASH score for all included pa-
tients was 26.7; 30% of the patients had an abnormal DASH 
score. When comparing the DASH scores of our participants 
with those of patients after hand injuries, our findings can be 
interpreted as “severely functionally impaired” (21). No as-
sociation was found with disease duration: high scores were 
already observed in an early stage of the disease. The high 
DASH scores seem to be in contrast with the NRS score for 
the use of hands, which was 2.99 in the dominant hand and 
2.59 in the non-dominant hand. It is difficult to understand this 
discrepancy, so there is a need for further study to determine 
the precise nature of the limitations.
In general, we had not expected to find such high prevalences 
of hand symptoms and impairments. on the other hand, we had 
expected to find an association with disease duration for most 
symptoms and impairments, and we were surprised that we 
could not determine a clear transition point after which there is 
a higher prevalence of symptoms and impairments: symptoms, 
impairments and activity limitations were already found in the 
sub-group with the shortest disease duration (2–4 years). 
Although there was a high percentage of non-participants, we 
believe that our study population is representative for the total 
group of RA patients in our eAC cohort. The mean age of the 
participants was higher than the mean age of the total cohort, 
and they had a trend towards a slightly higher DAS28 score. 
This might have led to an over-estimation of the prevalence 
of symptoms and impairments in our population. However, we 
estimate that this will only be a minor over-estimation, because 
of the equal distribution in both cohorts of radiographically 
determined joint damage and the findings of the HAQ with its 
category score HAQ-grip at the time of our study.
In conclusion, in our representative sample of 200 RA pa-
tients there was a high prevalence of hand and wrist symptoms 
and impairments, despite low disease activity. only some 
symptoms and impairments were associated with disease 
duration (subjectively experienced less stiffness of the hand, 
and more objectively assessed limited pROM of the finger 
joints, more Z-deformity of the thumb, and more tendinitis of 
the extensor tendons), but most were already highly prevalent 
in the early stages of the disease (limited pRoM of the wrist, 
stenosing tenosynovitis of the finger flexors, and involvement 
of the CMC-1 joint). Although the observed impairments might 
not be very severe, they did seem to lead to activity limitations 
in 30% of the patients. Based on our findings, together with the 
tendency of patients to under-report their hand problems, we 
recommend that physicians specifically ask about symptoms 
and screen for hand and wrist impairments, starting no later 
than 2 years after the diagnosis of RA. Via such a screening, 
timely and adequate non-pharmacological treatment can be 
provided in order to minimize further loss of hand function 
and increased activity limitations in patients with RA.
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